Table 1 Overview of laboratory investigations in Patient 1
Laboratory finding | Normal range | Clinic | Day 1 | Day 2 | Day 4 | Day 6 | Day 8 |
|---|---|---|---|---|---|---|---|
WBC (× 109/L) | 3.50–9.50 | 20.00 | 20.78 |  | 10.62 | 7.17 |  |
 GR% | 40–75 | 64 | 37 |  | 58 | 46 |  |
 GR# (× 109/L) | 1.80–6.30 | 12.3 | 7.70 |  |  | 3.31 |  |
 LY% | 20–50 | 21.9 | 47 |  | 25 | 32 |  |
 LY# (×109/L) | 1.10–3.20 | 4.38 | 9.83 |  |  | 2.31 |  |
 HGB (g/L) | 115–150 | 155 | 146 |  |  | 144 |  |
 PLT (×109/L) | 125–350 | 66 | 106 |  |  | 473 |  |
 ALT (U/L) | 9.0–50.0 | 228 | 141 |  |  |  | 22 |
 AST (U/L) | 15.0–40.0 | 235 | 141 |  |  |  | 28 |
 LDH (U/L) | 120–250 | 764 | 660 |  | 462 |  | 293 |
 HBD (U/L) | 72.0–182.0 | 537 | 517 |  |  |  | 236 |
 Ca (mmol/L) | 2.25–2.67 | 1.93 | / | 1.97 | / | / | 2.42 |
 ALB (g/L) | 40.0–55.0 | 33.7 | 32.4 |  |  |  | 38.1 |
 Ferritin (μg/L) | 20.0–200.0 | / | / | 1291.5 |  |  | 149.4 |
 C3 (g/L) | 0.9–1.5 | / | / | 0.73 | 0.99 |  |  |
 CRP (mg/L) | 0.00–3.00 |  |  | 14.2 | 10.60 |  |  |
 BUN (mmol/L) | 2.6–7.5 | 13.32 | 12.47 | 11.44 |  | 8.72 | 5.50 |
 Scr (μmol/L) | 50–80 | 104 | 96.2 | 99.8 | 122.7 | 75.3 | 57.9 |
 eGFR (ml/min) | 80–120 | 64 | 69 |  | 54.3 | 88.5 |  |
 Proteinuria (g/24 h) | -, 0–0.15 | 3+ |  | 2+ | 1.24 | – | 0.02 |
Hematuria (/HPF) | -, 0–3 | 2+, RBC 1.3/HPF |  |  |  |  |  |
MP - Ab | < 1:40 |  |  | 1:80 |  |  |  |
IgM capture ELISA anti- Hantaan virus | – | / | / | / | / | + |  |